Corbus Pharmaceuticals Holdings (CRBP) Current Assets (2013 - 2025)

Corbus Pharmaceuticals Holdings' Current Assets history runs 13 years deep, the most recent figure standing at $167.0 million for Q4 2025.

• In Q4 2025, Current Assets rose 9.14% year-over-year to $167.0 million; the TTM figure through Dec 2025 stood at $167.0 million (up 9.14% YoY), while the FY2025 annual figure was $167.0 million, up 9.14% from the prior year.
• Current Assets was $167.0 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $107.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $167.0 million in Q4 2025 to a low of $23.5 million in Q4 2023.
• Historically, Current Assets has averaged $100.1 million across 5 years, with a median of $109.6 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Current Assets sank 60.87% in 2023, then soared 549.69% in 2024.
• A 5-year view of Current Assets shows it stood at $100.2 million in 2021, then tumbled by 39.94% to $60.2 million in 2022, then tumbled by 60.87% to $23.5 million in 2023, then jumped by 549.69% to $153.0 million in 2024, then gained by 9.14% to $167.0 million in 2025.
• The last three Current Assets figures came in at $167.0 million (Q4 2025), $107.6 million (Q3 2025), and $122.8 million (Q2 2025), per Business Quant data.